Table 4 Statistical summary for gene set enrichment analysis of the histaminergic genes of interest in the replication data set

From: Altered expression of histamine signaling genes in autism spectrum disorder

Gene set

Up

P-value

Up

q-value

Effect size g

Mixed

P-value

Mixed

q-value

Effect size g

Number of

genes

Up active prop

Mixed active prop

Hypothesis-driven gene set

0.441

0.588

0.16 (−0.43, 0.75)

0.009

0.026

0.67 (0.07, 1.28)

4

0.25

0.50

GO: histamine receptor activity

0.656

0.749

0.09 (−0.49, 0.68)

0.009

0.026

0.67 (0.07, 1.28)

3

0.33

0.67

GeneRIF: histaminergic

0.904

0.904

0.04 (−0.55, 0.62)

0.008

0.026

0.67 (0.07, 1.28)

5

0.20

0.60

GeneRIF: histamine

0.080

0.150

0.43 (−0.17, 1.02)

0.170

0.269

0.33 (−0.27, 0.92)

40

0.20

0.25

  1. Abbreviation: GO, Gene Ontology.
  2. Summary of results for the gene set enrichment tests of the histaminergic genes in the replication data set. The results are shown with the controls as the reference group. Therefore, the hypothesis of ‘Up’ refers to the gene set being increased in autism spectrum disorder (ASD) patients as compared with controls, whereas the hypothesis of ‘Mixed’ refers to the gene set including genes with extreme t-statistics in both directions. Thus, as the results indicate that several of the gene sets show altered expression in ASD, the active prop is the proportion of genes in the set contributing meaningfully to significance, defined as those with squared z-values greater than 2.